Bio-Techne Corporation (TECH)

FairStock Score: 33/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look at Bio-Techne as a financially sturdy life-science supplier, but not a bargain. At the 2026-10-26 close of $72.69, FairStock calculates a P/E of 62.66, P/B of 5.38, EV/EBITDA of 32.79 and FCF yield of only 2.3%; the Graham Number is $18.78, leaving a negative margin of safety of 286.32%. Those are demanding prices for a company whose filed fiscal year 2026, ended 2026-06-30, revenue was $1.2B, net income was $181.9M and diluted EPS was $1.16. In fiscal year 2025, ended 2025-06-30, net income was $73.4M and diluted EPS was $0.46, while fiscal year 2024, ended 2024-06-30, had net income of $168.1M and diluted EPS of $1.05, so profit has been volatile. Revenue was $1.2B in fiscal year 2025, ended 2025-06-30, and $1.2B in fiscal year 2024, ended 2024-06-30. In fiscal Q3 2026, the quarter ended 2026-03-31, revenue was $311.4M and net income was $51.0M; in fiscal Q2 2026, the quarter ended 2025-12-31, revenue was $295.9M and net income was $38.0M. The balance sheet is a strength: D/E 0.14, Altman Z-Score 15.40 and Piotroski F-Score 8/9. But FairStock's ROE of 9.03% and ROCE of 6.67% are modest, and its Lynch category is SLOW GROWER, with 5.3% profit and 5.5% revenue growth over five years. The filed numbers do not prove a wide moat; flat revenue and modest returns suggest pricing power is not showing up. FairStock Score 33/100 reinforces caution, and the numbers leave little value cushion.

In plain English: Bio-Techne makes supplies and tools used in life-science research, diagnostics, and bioprocessing. The business looks financially safe, with little debt and solid cash flow, but sales have been nearly flat and returns are modest. At $72.69, the price looks expensive compared with its earnings and accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2026 10-Q (period ended 2025-12-31) · fiscal Q1 2026 10-Q (period ended 2025-09-30) · fiscal Q3 2025 10-Q (period ended 2025-03-31) · FY2026 10-K (period ended 2026-06-30) · FY2025 10-K (period ended 2025-06-30) · FY2024 10-K (period ended 2024-06-30)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer